Open AccessMonitoring and Treatment of Coagulation Disorders in End-Stage Liver Disease
Author(s) -
Fuat H. Saner,
Carmen Kirchner
Publication year - 2016
Publication title -
visceral medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.598
H-Index - 17
eISSN - 2297-475X
pISSN - 2297-4725
DOI - 10.1159/000446304
Subject(s) - medicine , hemostasis , partial thromboplastin time , liver transplantation , cirrhosis , intensive care medicine , liver disease , coagulation testing , coagulation , surgery , transplantation
Patients with end-stage liver disease (ESLD) are assumed to be at high risk of bleeding when undergoing any kind of invasive intervention (any kind of operation, including transplantation or minimally invasive interventions). Both bleeding and thrombosis are associated with a poor outcome.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom